How does screening differ from diagnosis regarding scope?
Screening is rapid and population-based, whereas diagnosis is comprehensive and individualized
11
New cards
How does screening differ from diagnosis regarding management?
Screening requires referral, whereas diagnosis leads to treatment initiation
12
New cards
What is the purpose of screening outcomes?
To identify individuals who require further evaluation
13
New cards
Can a screening establish a definitive diagnosis?
No
14
New cards
What is screening validity?
Whether the test tells the truth
15
New cards
What is a true positive (TP)?
Disease is present and the screening test is positive
16
New cards
What is a true negative (TN)?
Disease is absent and the screening test is negative
17
New cards
What is a false positive (FP)?
Disease is absent but the test indicates disease is present
18
New cards
What is a false negative (FN)?
Disease is present but the test misses the disease
19
New cards
What ethical concern may arise from IOP screening compared with Goldmann tonometry?
The screening may read IOP higher than the gold standard and create false positives
20
New cards
How do false-positive screening results affect patients?
They can negatively affect patient welfare
21
New cards
What is sensitivity?
The ability of a screening test to detect disease
22
New cards
What is the formula for sensitivity?
TP ÷ (TP + FN) × 100
23
New cards
What does high sensitivity accomplish?
Minimizes missed disease
24
New cards
How does high sensitivity support beneficence?
By reducing harm from missed diagnoses
25
New cards
What is specificity?
The ability of a screening test to correctly rule out disease
26
New cards
What is the formula for specificity?
TN ÷ (TN + FP) × 100
27
New cards
What does high specificity accomplish?
Reduces unnecessary anxiety and unnecessary referrals
28
New cards
In glaucoma screening, which may be equally or more important than specificity?
Sensitivity
29
New cards
Why is sensitivity especially important in glaucoma screening?
False negatives may delay glaucoma diagnosis
30
New cards
What characteristics should an ideal screening test have?
Adequate sensitivity and specificity
31
New cards
What determines the relative importance of sensitivity versus specificity?
The goals of the screening program and consequences of false positives versus false negatives
32
New cards
What is Positive Predictive Value (PPV)?
The likelihood that a person who fails a screening actually has the disease being screened for
33
New cards
Why is PPV important in vision screening programs?
It evaluates how effectively a screening identifies true disease in the population
34
New cards
Why can patients with elevated IOP identified by screening fail to have glaucoma?
Elevated IOP does not necessarily mean glaucoma is present
35
New cards
How does disease prevalence affect PPV?
Low disease prevalence lowers PPV, even with good sensitivity and specificity
36
New cards
What does a low PPV indicate?
Many individuals referred after screening do not actually have the disease
37
New cards
What problems can result from a low PPV?
Increased anxiety, increased costs, and unnecessary follow-up testing
38
New cards
What is Negative Predictive Value (NPV)?
The likelihood that a person with a negative screening result truly does not have the disease
39
New cards
Why does disease prevalence affect predictive values?
Predictive values depend on the proportion of disease within the screened population
40
New cards
What is reliability in a screening program?
Consistency of screening results
41
New cards
What factors affect screening reliability?
Examiner training, calibration, lighting and environment, test protocol, and sample size
42
New cards
What is yield in a screening program?
The number of previously unknown cases identified
43
New cards
What factors increase screening yield?
Greater sensitivity, high-risk populations, and greater disease prevalence
44
New cards
What factors should be considered when designing a screening program?
Disease prevalence, clinical consequences, resource availability, risk tolerance, follow-up access, ethical implications, and screening frequency
45
New cards
What are the community benefits of screening programs?
Early disease detection, reduced disability, increased health literacy, improved access, and population surveillance
46
New cards
Where can vision screenings be used as outreach programs?
Schools, community centers, senior centers, and workplaces
47
New cards
What are potential harms of false-positive screening results?
Anxiety, increased cost, and unnecessary testing
48
New cards
What are potential harms of false-negative screening results?
Missed disease, delayed treatment, and progression to disability
49
New cards
What determines whether false positives or false negatives are more harmful?
Disease severity, treatment availability, and public health priorities
50
New cards
What are the four core ethical principles emphasized in the lecture?
Autonomy, beneficence, nonmaleficence, and justice
51
New cards
What does autonomy refer to in healthcare ethics?
Respecting the patient's right to make informed decisions
52
New cards
What does beneficence refer to in healthcare ethics?
Promoting patient welfare and doing good
53
New cards
What does nonmaleficence refer to in healthcare ethics?
Avoiding harm
54
New cards
What does justice refer to in healthcare ethics?
Fairness and equitable access to care
55
New cards
What responsibilities are included in the code of ethics discussed in the lecture?
Keep patient welfare uppermost, maintain competence, ensure access to care, promote public health, maintain confidentiality, and collaborate appropriately
56
New cards
What should ethical screening programs accomplish?
Benefit participants, provide referral pathways, respect privacy, and avoid exploitation
57
New cards
What is the first step in the ethical decision-making framework?
Evaluate ethical principles and identify the ethical problem or dilemma
58
New cards
What does the first step of the ethical decision-making framework involve?
Recognizing the ethical issue and identifying relevant principles, laws, standards, and conflicts
59
New cards
What is the second step in the ethical decision-making framework?
Gather relevant facts
60
New cards
What information should be gathered during ethical decision-making?
Clinical, social, and legal information essential for informed analysis
61
New cards
What additional actions are recommended when gathering relevant facts?
Weigh costs and benefits, consult experts while maintaining confidentiality, and review similar cases
62
New cards
What is the third step in the ethical decision-making framework?
Decide and act
63
New cards
What does the third step require?
Choose the most ethically sound action, document reasoning, and act
64
New cards
What does the phrase "no decision is a decision" mean in ethical decision-making?
Failing to act is itself a decision with consequences
65
New cards
What is the fourth step in the ethical decision-making framework?
Reflection
66
New cards
What occurs during the reflection phase of ethical decision-making?
Evaluation of outcomes and learning for future dilemmas
67
New cards
What ethical principle asks whether patients benefit from screening if confirmatory testing is unlikely?
Beneficence
68
New cards
What potential harms in screening relate to nonmaleficence?
False-positive anxiety, labeling patients as having disease, and burdensome referrals
69
New cards
What issue related to screening reflects the principle of justice?
Whether patients have equitable access to diagnosis and treatment
70
New cards
What obligation exists under professional competence and integrity?
Using reliable equipment and valid screening procedures
71
New cards
What is fidelity and patient advocacy?
The responsibility to act in the patient's best interests
72
New cards
What is a conflict of interest in healthcare?
When non-clinical motivations may influence healthcare decisions
73
New cards
What actions were recommended when screening equipment accuracy is in doubt?
Stop using the device, calibrate or replace it, document concerns, and investigate results
74
New cards
What actions improve follow-up access after screening?
Develop on-site follow-up, mobile exams, transportation assistance, and screening program modifications
75
New cards
When should concerns be escalated through professional channels?
When patient welfare continues to be compromised
76
New cards
When is a screening program ethically successful?
When patients have a realistic opportunity to obtain appropriate follow-up care
77
New cards
Why is screening without access to diagnosis and treatment ethically concerning?
It raises concerns regarding beneficence, nonmaleficence, justice, and professional responsibility
78
New cards
What technologies were highlighted in modern optometry?
AI, imaging, topography, telehealth, and genomics
79
New cards
What are examples of technology used in optometry?
AI retinal screening, OCT, telehealth, corneal topography, automated visual fields, and genetic testing
80
New cards
What benefits can technology provide in optometry?
Improved detection, greater efficiency, and increased access
81
New cards
What challenges accompany technology in optometry?
Cost, privacy concerns, bias, over-reliance, accuracy issues, training requirements, and technology failures
82
New cards
What key questions should be asked before adopting technology in optometry?
Is it validated, does it improve outcomes, is performance equitable, are patients informed, and is human oversight maintained?
83
New cards
What ethical risks are associated with technology in optometry?
Algorithm bias, overdiagnosis, over-referral, and commercial conflicts of interest
84
New cards
What role should technology play in clinical care?
Technology should support, not replace, professional judgment
85
New cards
What privacy concerns are introduced by healthcare technology?
Genetic screening, AI image databases, cloud storage, and patient data sharing
86
New cards
What ethical obligations arise when using patient data and technology?
Informed consent, transparency, confidentiality, and data security
87
New cards
What right do patients have regarding healthcare technology?
The right to understand how their information will be used
88
New cards
What AI systems were discussed for diabetic retinopathy screening?
LumineticsCore, EyeArt, AEYE-DS, and iPredict-DR
89
New cards
What AI system was discussed for AMD monitoring?
SCANLY Home OCT
90
New cards
What is the primary ethical goal of AI in optometry?
Enhancing patient care
91
New cards
Will AI replace clinical judgment in optometry?
No
92
New cards
How should optometrists view AI?
As a tool that supports care but does not make diagnoses or treatment decisions
93
New cards
Who is responsible for patient outcomes when AI is used?
The clinician
94
New cards
What procedures generally require in-person care rather than telehealth?